Bare Act Search Results

Central Excise Tariff Act, 1985 Chapter 30

Title: Pharm Aceutical Products

State: Central

Year: 1985

.....from bulk packs to retail packs or the adoption of any other treatment to render the product marketable to the consumer, shall amount to 'manufacture'. 7. In relation to products of heading 3005, "brand name" means a brand name, whether registered or not, that is to say, a name or a mark, such as a symbol, monogram, label, signature or invented words or any writing which is used in relation to a product, for the purpose of indicating, or so as to indicate, a connection in the course of trade between the product and some person using such name or mark with or without any indication of the identity of that person. Tariff Item Description of goods Unit Rate of duty (1) (2) (3) (4) 3001 GLANDS AND OTHER ORGANS FOR ORGANO-THERAPEUTIC USES, DRIED, WHETHER OR NOT POWDERED; EXTRACTS OF GLANDS OR OTHER ORGANS OR OF THEIR SECRETIONS FOR ORGANO-THERAPEUTIC USES; HEPARIN AND ITS SALTS; OTHER HUMAN OR ANIMAL SUBSTANCES PREPARED FOR THERAPEUTIC OR PROPHYLACTIC USES, NOT ELSEWHERE SPECIFIED OR INCLUDED 3 [***] 3002 .....

Food Safety and Standards Act, 2006 Chapter IV

Title: General Provisions as to Articles of Food

State: Central

Year: 2006

.....foods, functional foods, proprietary foods, etc. Save as otherwise provided under this Act and regulations made thereunder, no person shall manufacture, distribute, sell or import any novel food, genetically modified articles of food, irradiated food, organic foods, foods for special dietary uses, functional foods, neutraceuticals, health supplements, proprietary foods and such other articles of food which the Central Government may notify in this behalf. Explanation.--For the purposes of this section,-- (1) "foods for special dietary uses or functional foods or nutraceuticals or health supplements" means: (a) foods which are specially processed or formulated to satisfy particular dietary requirements which exist because of a particular physical or physiological condition or specific diseases and disorders and which are presented as such, wherein the composition of these foodstuffs must differ significantly from the composition of ordinary foods of comparable nature, if such ordinary foods exist, and may contain one or more of the following ingredients, namely:-- (i) plants or botanicals or their parts in the form of powder, concentrate or extract in water, ethyl.....

Food Safety and Standards Act, 2006 Section 22

Title: Genetically Modified Foods, Organic Foods, Functional Foods, Proprietary Foods, Etc.

State: Central

Year: 2006

Save as otherwise provided under this Act and regulations made thereunder, no person shall manufacture, distribute, sell or import any novel food, genetically modified articles of food, irradiated food, organic foods, foods for special dietary uses, functional foods, neutraceuticals, health supplements, proprietary foods and such other articles of food which the Central Government may notify in this behalf. Explanation.--For the purposes of this section,-- (1) "foods for special dietary uses or functional foods or nutraceuticals or health supplements" means: (a) foods which are specially processed or formulated to satisfy particular dietary requirements which exist because of a particular physical or physiological condition or specific diseases and disorders and which are presented as such, wherein the composition of these foodstuffs must differ significantly from the composition of ordinary foods of comparable nature, if such ordinary foods exist, and may contain one or more of the following ingredients, namely:-- (i) plants or botanicals or their parts in the form of powder, concentrate or extract in water, ethyl alcohol or hydro alcoholic extract, single or in.....

Central Excise Tariff (Amendment) Act, 2004 Chapter XXX

Title: Pharmaceutical Products

State: Central

Year: 2004

.....from bulk packs to retail packs or the adoption of any other treatment to render the product marketable to the consumer, shall amount to 'manufacture'. 7. In relation to products of heading 3005, "brand name" means a brand name, whether registered or not, that is to say, a name or a mark, such as a symbol, monogram, label, signature or invented words or any writing which is used in relation to a product, for the purpose of indicating, or so as to indicate, a connection in the course of trade between the product and some person using such name or mark with or without any indication of the identity of that person. For effective rates of Cess on the specified goods of this Chapter - please see Appendix IV. Tariff Item Description of goods Unit Rate of duty (1) (2) (3) (4) 3001 GLANDS AND OTHER ORGANS FOR ORGANO-THERAPEUTIC USES, DRIED, WHETHER OR NOT POWDERED; EXTRACTS OF GLANDS OR OTHER ORGANS OR OF THEIR SECRETIONS FOR ORGANO-THERAPEUTIC USES; HEPARIN AND ITS SALTS; OTHER HUMAN OR ANIMAL SUBSTANCES PREPARED FOR THERAPEUTIC OR PROPHYLACTIC USES, NOT ELSEWHERE SPECIFIED OR INCLUDED .....

Customs Tariff Act 1975 Chapter 30

Title: Pharmaceutical Products

State: Central

Year: 1975

.....[10%]10 3004 90 45 - Etoposide kg. [10%]10 [10%]10 3004 90 46 - Actinomycin D Dactinomycin and doxorubicin kg. [10%]10 [10%]10 3004 90 47 - L-Asparaginase, cisplatin and carboplatin kg. [10%]10 [10%]10 3004 90 48 - Tamoxifen kg. [10%]10 [10%]10 3004 90 49 - Other kg. [10%]10 [10%]10 --- Antitubercular drugs; antileprotic drugs; antimalarial drugs : 3004 90 51 - Isoniazid kg. [10%]10 [10%]10 3004 90 52 - Rifampicin kg. [10%]10 [10%]10 3004 90 53 - Pyrazinamide and ethambutol kg. [10%]10 [10%]10 3004 90 54 - Streptomycin kg. [10%]10 [10%]10 3004 90 55 - Dapsone (DDS), acedapsone (DADDS), solopsone and clofazimine .....

Customs Tariff (Amendment) Act, 2003 Chapter XXX

Title: Pharmaceutical Products

State: Central

Year: 2003

..... ---- Paclitaxel and docetaxel kg. 30% 20% 30049045 ---- Etoposide kg. 30% 20% 30049046 ---- Actjnomycin D Dactinomycin and doxorubicin kg. 30% 20% 30049047 ---- L-Asparaginase, 9isplatin and carboplatin kg. 30% 20% 30049048 ---- Tamoxifen kg. 30% 20% 30049049 ---- Other kg. 30% 20% --- Antitubercular drugs; antiieprotic drugs; antimalarial drugs : 30049051 ----- Isoniazid kg. 30% 20% 30049052 ---- Rifampicin kg. 30% 20% 30049053 ---- Pyrazinamide and ethambutol kg. 30% 20% 30049054 ---- Streptomycin kg. 30% 20% 30049055 ---- Dapsone (DDS), acedapsone (DADDS), solopsone and clofazimine kg. 30% 20% 30049056 ---- Chloroquine, amodiaquine, mefloquine, quinine, chloroguamide, pyrimethamine kg. 30% 20% 30049057 ---- Other antitubercular drugs kg. 30% 20% 30049058 ---- Other antiieprotic drugs kg. 30% .....

Finance Act, 2011, (Central) Schedule V

Title: Fifth Schedule

State: Central

Year: 2011

.....antibody fragments, antibody conjugates and antibody fragment conjugates, interleukins, interferons (IFN), chemokines and certain tumor necrosis factors (TNF), growth factors (GF), hematopoietins and colony stimulating factors (CSF). ; (iii) in heading 3002,-- (a) for the entry in column (2), the following entry shall be substituted, namely:-- HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICRO-ORGANISMS (EXCLUDING YEASTS) AND SIMILAR PRODUCTS ; (b) for sub-heading 3002 10, the following shall be substituted, namely:-- 3002 10 - Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes: ; (23) in Chapter 37, in heading 3702,-- (i) for sub-heading 3702 51, tariff items 3702 51 10 to 3702 51 90, sub-heading 3702 52, tariff items 3702 52 10 to 3702 52 90 and the entries relating thereto, the following shall be substituted, namely:-- 3702 52 - - Of a width not exceeding 16 mm : 3702.....

Finance Act, 2011, (Central) Schedule XI

Title: Eleventh Schedule

State: Central

Year: 2011

.....antibody fragments, antibody conjugates and antibody fragment conjugates, interleukins, interferons (IFN), chemokines and certain tumor necrosis factors (TNF), growth factors (GF), hematopoietins and colony stimulating factors (CSF). ; (iii) in heading 3002,-- (a) for the entry in column (2), the following entry shall be substituted, namely:-- HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICRO-ORGANISMS (EXCLUDING YEASTS) AND SIMILAR PRODUCTS ; (b) for sub-heading 3002 10 and the entry relating thereto, the following shall be substituted, namely:-- 3002 10 - Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes: ; (23) in Chapter 37, in heading 3702,-- (i) for sub-heading 3702 51, tariff items 3702 51 10 to 3702 51 90, sub-heading 3702 52, tariff items 3702 52 10 to 3702 52 90 and the entries relating thereto, the following shall be substituted, namely:-- 3702 52 - - Of.....

Biological Diversity Act, 2002 Complete Act

State: Central

Year: 2002

.....of any Panchayats or Municipalities, institutions of self-Government constituted under any other provision of the Constitution or any Central Act or State Act; (i) "member" means a member of the National Biodiversity Authority or a State Biodiversity Board and includes the Chairperson; (j) "National Biodiversity Authority" means the National Biodiversity Authority established under Sec. 8; (k) "prescribed" means prescribed by rules made under this Act; (l) "regulations" means regulations made under this Act; (m) "research" means study or systematic investigation of any biological resource or technological application, that uses biological systems, living organisms or derivatives thereof to make or modify products or processes for any use; (n) "State Biodiversity Board" means the State Biodiversity Board established under Sec. 22; (o) "sustainable use" means the use of components of biological diversity in such manner and at such rate that does not lead to the long-term decline of the biological diversity thereby maintaining its potential to meet the needs and aspirations of present and future generations; (p) "value added products" means products which may contain.....

Food Safety and Standards Act, 2006 Complete Act

State: Central

Year: 2006

.....results meet with objectives of food safety and the claims made in that behalf; (s) "food safety Management System" means the adoption of Good Manufacturing Practices, Good Hygienic Practices, Hazard Analysis and Critical Control Point and such other practices as may be specified by regulation, for the food business; (t) "food safety Officer" means an officer appointed under s.37; (u) "hazard" means a biological, chemical or physical agent in, or condition of, food with the potential to cause an adverse health effect; (v) "import" means bringing into India any article of food by land, sea or air; (w) "improvement notice" means a notice issued under s.32 of this Act; (x) "infant food" and "infant milk substitute" shall have the meanings assigned to them in clauses (f) and (g) of sub-section (1) of s.2 of the Infant Milk Substitutes, Feeding Bottles and Infant foods (Regulation of Production, Supply and Distribution) act, 1992 (41 of 1992), respectively; (y) "ingredient" means any substance, including a food additive used in the manufacture or preparation of food and present in the final product, possibly in a modified form; (z) "label" means any tag, brand, mark, pictorial or.....